ARTICLE | Finance

Ebb & Flow

August 8, 2005 7:00 AM UTC

Just when it was beginning to look like the biotech financing window was nearing the end of its natural lifespan, an inflow of money into the sector is driving up the indices and fueling a spate of follow-ons and other financings.

Already this quarter, nine companies have priced follow-ons, including seven U.S. companies, raising a total of $685.4 million. The entire second quarter totaled seven follow-ons by six companies (four U.S. companies), raising $497.8 million (see "Following Follow-Ons"). ...